Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Histone deacetylases (HDACs) mediate changes in nucleosome conformation and are important in the regulation of gene expression. HDACs are involved in cell-cycle progression and differentiation, and their deregulation is associated with several cancers. HDAC inhibitors, such as trichostatin A (TSA) and suberoylanilide hydroxamic acid (SAHA), have anti-tumour effects, as they can inhibit cell growth, induce terminal differentiation and prevent the formation of tumours in mice models, and they are effective in the treatment of promyelocytic leukemia. Here we describe the structure of the histone deacetylase catalytic core, as revealed by the crystal structure of a homologue from the hyperthermophilic bacterium Aquifex aeolicus, that shares 35.2% identity with human HDAC1 over 375 residues, deacetylates histones in vitro and is inhibited by TSA and SAHA. The deacetylase, deacetylase-TSA and deacetylase-SAHA structures reveal an active site consisting of a tubular pocket, a zinc-binding site and two Asp-His charge-relay systems, and establish the mechanism of HDAC inhibition. The residues that make up the active site and contact the inhibitors are conserved across the HDAC family. These structures also suggest a mechanism for the deacetylation reaction and provide a framework for the further development of HDAC inhibitors as antitumour agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The conformation of this loop is virtually identical in the three HDLP structures (Finnin et al., 1999), suggesting that the surface of HDLP is less malleable than that of HDAC8 around the binding site pocket.”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Finnin et al., 1999
In the citing paper
“The apparent reduced flexibility in the HDLP surface may also explain why it is less efficient in histone deacetylase assays (Finnin et al., 1999).”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Finnin et al., 1999
In the citing paper
“Finnin et al. (1999) have suggested that H143 protonates the lysine after the carbon-nitrogen scissile bond breaks.”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Finnin et al., 1999
In the citing paper
“HDAC6 also contributes to mitochondrial trafficking and misfolded protein clearance (Perry et al., 2017; Finnin et al., 1999), highlighting the HDAC6–microtubule–mitochondria axis as an important regulatory node beyond chromatin-dependent mechanisms.”
From Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook (2026) · cites this paper as Finnin et al., 1999
In the citing paper
“HDAC6 also contributes to mitochondrial trafficking and misfolded protein clearance (Perry et al., 2017; Finnin et al., 1999), highlighting the HDAC6–microtubule–mitochondria axis as an important regulatory node beyond chromatin-dependent mechanisms.”
From Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook (2026) · cites this paper as Finnin et al., 1999
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
[26] Raster3D: Photorealistic molecular graphics
Merritt, E. A., & Bacon, D. J. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)77028-9 · Cited by 3,739
The relation between the divergence of sequence and structure in proteins.
Chothia, C., & Lesk, A. M. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04288.x · Cited by 2,458
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815
The complete genome of the hyperthermophilic bacterium Aquifex aeolicus
Deckert, G., Warren, P. V., Gaasterland, T., Young, W. G., Lenox, A. L., Graham, D. E., Overbeek, R., Snead, M. A., Keller, M., Aujay, M., et al. (1998) · Nature · doi:10.1038/32831 · Cited by 1,097
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., & Marks, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3003 · Cited by 914
Self-citation
Research works printed but not linked: 2
- Cohen,L. A. et al. Inhibition of N-methylnitrosourea-induced tumours by the cytodifferentiating agent, suberanilohydroxamic acid (SAHA). Proc. AACR 39, 108, abstr. 736 (1998).
- Desai,D., El-Bayoumy,K. & Amin,S. Chemopreventive efficacy of suberanilohydroxamic acid (SAHA), a cytodifferentiating agent, against tobacco-specific nitrosamine 4-(methylinitros-amino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in female A/J mice. Proc. AACR 40, 2396, abstr. 362 (1999).
Cited by
Items 701–800 of 1,007
Ailenberg, M., & Silverman, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02420-8 · Cited by 44
Design of novel histone deacetylase inhibitors
Siliphaivanh, P., Harrington, P., Witter, D. J., Otte, K. M., Tempest, P. A., Kattar, S. D., Kral, A. M., Fleming, J. C., Deshmukh, S. V., Harsch, A., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.05.080 · Cited by 44
Proteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid
Tong, A., Zhang, H., Li, Z., Gou, L., Wang, Z., Wei, H., Tang, M., Liang, S., Chen, L., Huang, C., et al. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0536-2 · Cited by 44
Lammers, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.757179 · Cited by 44
Kozikowski, A. P., Chen, Y., Subhasish, T., Lewin, N. E., Blumberg, P. M., Zhong, Z., D'Annibale, M. A., Wang, W., Shen, Y., & Langley, B. (2009) · ChemMedChem · doi:10.1002/cmdc.200900045 · Cited by 44
Morończyk, J., Brąszewska-Zalewska, A., Wójcikowska, B., Chwiałkowska, K., Nowak, K., Wójcik, A. M., Kwaśniewski, M., & Gaj, M. D. (2022) · Cells · doi:10.3390/cells11050863 · Cited by 44
Shi, Y., Li, Z., Han, X., Yi, J.-H., Wang, Z., Hou, J., Feng, C., Fang, Q., Wang, H. H., Zhang, P., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1455-1 · Cited by 44
Ragno, R., Simeoni, S., Valente, S., Massa, S., & Mai, A. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050556b · Cited by 44
Current HDAC Inhibitors in Clinical Trials
Bello, E. D., Noce, B., Fioravanti, R., & Mai, A. (2022) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2022.448 · Cited by 44
HDAC inhibitor-induced drug resistance involving ATP-binding cassette transporters (Review)
Ni, X., Li, L., & Pan, G. (2014) · Oncology Letters · doi:10.3892/ol.2014.2714 · Cited by 44
Design and Synthesis of a Potent Histone Deacetylase Inhibitor
Liu, T., Kapustin, G. V., & Etzkorn, F. A. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061082q · Cited by 43
Uba, A. İ., & Yelekçi, K. (2017) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2017.1384402 · Cited by 43
Identification of type-specific anticancer histone deacetylase inhibitors: road to success
Noureen, N., Rashid, H., & Kalsoom, S. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1324-y · Cited by 43
Chen, L., Petrelli, R., Gao, G. Y., Wilson, D. J., McLean, G. T., Jayaram, H. N., Sham, Y. Y., & Pankiewicz, K. W. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.06.081 · Cited by 43
Kuzmochka, C., Abdou, H. S., Haché, R. J. G., & Atlas, E. (2014) · Endocrinology · doi:10.1210/en.2014-1565 · Cited by 43
Curriculum vitae of HDAC6 in solid tumors
Zheng, Y., Kang, H., Wang, B., Zhu, Y.-Z., Mamun, M., Zhao, L., Nie, H., Liu, Y., Zhao, L., Zhang, X., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123219 · Cited by 43
Han, H., Feng, X., He, T., Wu, Y., He, T., Yue, Z., & Zhou, W. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14366 · Cited by 43
A three layered histone epigenetics in breast cancer metastasis
Nandy, D., Rajam, S. M., & Dutta, D. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00415-1 · Cited by 43
Prestegui-Martel, B., Bermúdez-Lugo, J. A., Chávez-Blanco, A. D., Dueñas‐González, A., García-Sánchez, J. R., Pérez-González, O. A., Martínez, I. I. P., Fragoso-Vázquez, M. J., Mendieta‐Wejebe, J. E., Correa-Basurto, A. M., et al. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1210138 · Cited by 43
Cironi, L., Petricevic, T., Vieira, V. F., Provero, P., Fusco, C., Buros, S. C., Fregni, G., Letovanec, I., Aguet, M., & Stamenkovic, I. (2016) · Scientific Reports · doi:10.1038/srep22113 · Cited by 43
Klan, N., Seuter, S., Schnur, N., Jung, M., & Steinhilber, D. (2003) · Biological Chemistry · doi:10.1515/bc.2003.086 · Cited by 43
Micco, S. D., Terracciano, S., Bruno, I., Rodriquez, M., Riccio, R., Taddei, M., & Bifulco, G. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.08.003 · Cited by 43
QSAR Studies of PC-3 cell line inhibition activity of TSA and SAHA-like hydroxamic acids
Wang, D., Wiest, O., Helquist, P. M., Lan-Hargest, H.-Y., & Wiech, N. L. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.11.062 · Cited by 43
Shin, S., Kim, M., Lee, S., Park, K., & Lee, C. H. (2017) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20045 · Cited by 43
Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review
Ali, S. R., Humphreys, K. J., McKinnon, R. A., & Michael, M. (2015) · Drug Development Research · doi:10.1002/ddr.21268 · Cited by 42
Kalyaanamoorthy, S., & Chen, Y. P. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200584f · Cited by 42
Hanif, M., Arshad, J. Z., Astin, J. W., Rana, Z., Zafar, A., Movassaghi, S., Leung, E. Y., Patel, K. D., Söhnel, T., Reynisson, J., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202005758 · Cited by 42
Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID components
Wheatley, N. C., Andrews, K. T., Tran, T. L., Lucke, A. J., Reid, R. C., & Fairlie, D. P. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.096 · Cited by 42
Huang, W., Chen, C., Chao, S.-W., Lee, S., Hsu, F., Lu, Y., Hung, M., & Chang, C. (2010) · ChemMedChem · doi:10.1002/cmdc.200900494 · Cited by 42
Structure‐Based Organic Synthesis of Drug Prototypes: A Personal Odyssey
Hanessian, S. (2006) · ChemMedChem · doi:10.1002/cmdc.200600203 · Cited by 42
Abdel-Atty, M. M., Farag, N. A., Kassab, S. E., Serya, R. A. T., & Abouzid, K. A. M. (2014) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2014.08.006 · Cited by 42
Ferreira, R. C., Popova, E. Y., James, J., Briones, M. R. S., Zhang, S. S.-M., & Barnstable, C. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.756643 · Cited by 42
Grolla, A. A., Podestà, V., Chini, M. G., Micco, S. D., Vallario, A., Genazzani, A. A., Canonico, P. L., Bifulco, G., Tron, G. C., Sorba, G., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801529c · Cited by 42
The Paradox of Histone Deacetylase Inhibitor-Mediated Modulation of Cellular Responses to Radiation
Karagiannis, T. C., & El‐Osta, A. (2006) · Cell Cycle · doi:10.4161/cc.5.3.2421 · Cited by 42
Liu, C., Zhang, Y., Li, J., Wang, Y., Ren, F., Zhou, Y., Wu, Y., Feng, Y., Zhou, Y., Su, F., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.620872 · Cited by 41
“formation of the -catenin TCF4 complex (30).”
MethodTherapeutic Potential of Isoform Selective Hdac Inhibitors for the Treatment of Schizophrenia
Weïwer, M., Lewis, M. C., Wagner, F. F., & Holson, E. B. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.141 · Cited by 41
Pyridylalanine‐Containing Hydroxamic Acids as Selective HDAC6 Inhibitors
Schäfer, S., Saunders, L., Schlimme, S., Valkov, V., Wagner, J. M., Kratz, F., Sippl, W., Verdin, E., & Jung, M. (2009) · ChemMedChem · doi:10.1002/cmdc.200800196 · Cited by 41
Zn2+-Dependent Histone Deacetylases in Plants: Structure and Evolution
Yruela, I., Moreno–Yruela, C., & Olsen, C. A. (2021) · Trends in Plant Science · doi:10.1016/j.tplants.2020.12.011 · Cited by 41
Bajbouj, K., Mawrin, C., Hartig, R., Schulze‐Luehrmann, J., Wilisch-Neumann, A., Roessner, A., & Schneider‐Stock, R. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0791-2 · Cited by 41
Deng, Z., Liu, X., Jin, J., Xu, H., Gao, Q., Wang, Y., & Zhao, J. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.16569 · Cited by 41
Shinsky, S. A., & Christianson, D. W. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00079 · Cited by 41
Ibrahim, T. S., Sheha, T. A., Abo-Dya, N. E., AlAwadh, M. A., Alhakamy, N. A., Abdel‐Samii, Z. K., Panda, S. S., Abuo‐Rahma, G. E. A., & Mohamed, M. F. A. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103797 · Cited by 41
HDAC6—An Emerging Target Against Chronic Myeloid Leukemia?
Losson, H., Schnekenburger, M., Dicato, M. A., & Diederich, M. F. (2020) · Cancers · doi:10.3390/cancers12020318 · Cited by 41
You, D., Richardson, J. R., & Aleksunes, L. M. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.089953 · Cited by 41
Rossetti, F., Furtado, M. D. A., Pak, T. K., Bailey, K., Shields, M. C., Chanda, S., Addis, M., Robertson, B. D., Moffett, M. C., Lumley, L. A., et al. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.02.010 · Cited by 41
Nelson, W. G. (2007) · Current Opinion in Urology · doi:10.1097/mou.0b013e3280eb110f · Cited by 41
Ning, C., Lu, C., Hu, L., Bi, Y.-J., Yao, L., He, Y., Liu, L., Liu, X., & Yu, N. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.03.034 · Cited by 41
Shindoh, N., Mori, M., Terada, Y., Oda, K., Amino, N., Kita, A., Taniguchi, M., Sohda, K., Nagai, K., Sowa, Y., et al. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.3.545 · Cited by 41
Histone acetyltransferases and deacetylase in Entamoeba histolytica
Ramakrishnan, G., Gilchrist, C. A., Musa, H., Torok, M. S., Grant, P. A., Mann, B. J., & Petri, W. A. (2004) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2004.09.002 · Cited by 41
Garmpis, N., Damaskos, C., Garmpi, A., Georgakopoulou, V., Sarantis, P., Antoniou, E., Karamouzis, M. V., Nonni, A., Schizas, D., Diamantis, E., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030223 · Cited by 41
Phosphorylation of histone H3 serine 28 modulates RNA polymerase III-dependent transcription
Zhang, Q., Zhong, Q., Evans, A. G., Levy, D., & Zhong, S. (2011) · Oncogene · doi:10.1038/onc.2011.105 · Cited by 41
White, N. R., Mulligan, P., King, P. J., & Sanderson, I. R. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000189345.31010.89 · Cited by 40
Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
Murata, M., Towatari, M., Kosugi, H., Tanimoto, M., Ueda, R., Saito, H., & Naoe, T. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00899.x · Cited by 40
Saha, A., Pandian, G. N., Sato, S., Taniguchi, J., Hashiya, K., Bando, T., & Sugiyama, H. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.05.002 · Cited by 40
Suzuki, T., Nagano, Y., Matsuura, A., Kohara, A., Ninomiya, S.-I., Kohda, K., & Miyata, N. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.048 · Cited by 40
Ortore, G., Colo, F. D., & Martinelli, A. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900288e · Cited by 40
Rooker, D. R., & Buccella, D. (2015) · Chemical Science · doi:10.1039/c5sc02704g · Cited by 40
Keshari, S., Wang, Y., Herr, D. R., Wang, S.-M., Yang, W.-C., Chuang, T., Chen, C., & Huang, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020312 · Cited by 40
Disulfide-bridged peptide macrobicycles from nature
Chung, B. K. W., & Yudin, A. K. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob01115a · Cited by 40
Kitano, A., Okada, Y., Yamanka, O., Shirai, K., Mohan, R. R., & Saika, S. (2010) · PubMed Central · Cited by 40
How the flexibility of human histone deacetylases influences ligand binding: an overview
Deschamps, N., Simões‐Pires, C. A., Carrupt, P., & Nurisso, A. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.01.004 · Cited by 39
Mercaptoamide-based non-hydroxamic acid type histone deacetylase inhibitors
Anandan, S., Ward, J. S., Brokx, R. D., Bray, M. R., Patel, D. V., & Xiao, X.-X. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.02.075 · Cited by 39
Ghosh, B., Zhao, W., Reis, S. A., Patnaik, D., Fass, D. M., Tsai, L., Mazitschek, R., & Haggarty, S. J. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.01.022 · Cited by 39
Synthesis and Biological Evaluation of C7‐Demethyl Largazole Analogues
Chen, F., Gao, A., Li, J. X., & Nan, F. (2009) · ChemMedChem · doi:10.1002/cmdc.200900125 · Cited by 39
Bacterial protein acetylation: mechanisms, functions, and methods for study
Rizo, J., & Encarnación-Guevara, S. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1408947 · Cited by 39
Nam, N., Huong, T. L., Dung, D. T. M., Dung, P. T. P., Oanh, D. T. K., Park, S. H., Kim, K., Han, B. W., Yun, J., Kang, J. S., et al. (2013) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2013.832238 · Cited by 39
Huang, W., Chen, C., Chao, S.-W., Yu, C.-C., Yang, C., Guh, J., Lin, Y.-C., Kuo, C.-I., Yang, P., & Chang, C.-I. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.06.002 · Cited by 39
Lochmanová, G., Ihnatová, I., Kuchaříková, H., Brabencová, S., Zachová, D., Fajkus, J., Zdráhal, Z., & Fojtová, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205093 · Cited by 39
Kudo, K., Ozaki, T., Shin‐ya, K., Nishiyama, M., & Kuzuyama, T. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b02071 · Cited by 39
Campbell, R. R., Kramár, E. A., Pham, L. V., Beardwood, J. H., Augustynski, A. S., López, A. J., Chitnis, O., Delima, G., Banihani, J., Matheos, D. P., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2829-20.2021 · Cited by 39
Hanessian, S., Auzzas, L., Giannini, G., Marzi, M., Cabri, W., Barbarino, M., Vesci, L., & Pisano, C. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.09.014 · Cited by 38
Reversible binding of zinc in Plasmodium falciparum Sir2: Structure and activity of the apoenzyme
Chakrabarty, S. P., & Balaram, H. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.06.010 · Cited by 38
Thaler, F., & Minucci, S. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.557660 · Cited by 38
Selective Photorelease of an Organometallic-Containing Enzyme Inhibitor
Leonidova, A., Mari, C., Aebersold, C., & Gasser, G. (2016) · Organometallics · doi:10.1021/acs.organomet.6b00029 · Cited by 38
Xu, J., Mao, J., Han, X. M., Shi, F., Gao, Q. F., Wang, T., Zhang, Z., Shan, Y., Fang, W., & Li, X. (2021) · Journal of Virology · doi:10.1128/jvi.00853-21 · Cited by 38
Epigenetic tools in potential anticancer therapy
Sebova, K., & Fridrichová, I. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32833a4352 · Cited by 38
Preclinical Studies of Chemotherapy Using Histone Deacetylase Inhibitors in Endometrial Cancer
Takai, N., & Narahara, H. (2010) · Obstetrics and Gynecology International · doi:10.1155/2010/923824 · Cited by 38
Biersack, B. (2016) · Non-coding RNA Research · doi:10.1016/j.ncrna.2016.09.001 · Cited by 38
Yi, T.-Z., Li, J., Han, X., Guo, J., Qu, Q., Guo, L., Sun, H.-D., & Tan, W. (2012) · Chemotherapy · doi:10.1159/000333077 · Cited by 38
Novel amide derivatives as inhibitors of histone deacetylase: Design, synthesis and SAR
Andrianov, V. G., Gailite, V., Loļa, D., Loža, E., Semenikhina, V. G., Kalvinsh, I., Finn, P. W., Petersen, K. D., Ritchie, J. W. A., Khan, N., et al. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.06.020 · Cited by 37
Deardorff, M. A., Porter, N. J., & Christianson, D. W. (2016) · Protein Science · doi:10.1002/pro.3030 · Cited by 37
Su, L., Deng, B., Liu, S., Li, L., Hu, B., Zhong, Y.-T., & Li, L. (2015) · Frontiers in Plant Science · doi:10.3389/fpls.2015.00512 · Cited by 37
Chemical Versatility in Catalysis and Inhibition of the Class IIb Histone Deacetylases
Christianson, D. W. (2024) · Accounts of Chemical Research · doi:10.1021/acs.accounts.3c00801 · Cited by 37
Recent advancement of HDAC inhibitors against breast cancer
Mehmood, S. A., Sahu, K. K., Sengupta, S., Partap, S., Karpoormath, R. V., Kumar, B., & Kumar, D. (2023) · Medical Oncology · doi:10.1007/s12032-023-02058-x · Cited by 37
Mechanisms of Metal-Dependent Hydrolases in Metabolism
Hernick, M., & Fierke, C. A. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00178-7 · Cited by 37
Chromatin heterogeneity modulates nuclear condensate dynamics and phase behavior
Xia, J., Zhao, J. Z., Strom, A. R., & Brangwynne, C. P. (2025) · Nature Communications · doi:10.1038/s41467-025-60771-9 · Cited by 37
Design and Synthesis of Cyclopeptide Analogues of the Potent Histone Deacetylase Inhibitor FR235222
Gomez‐Paloma, L., Bruno, I., Cini, E., Khochbin, S., Rodriquez, M., Taddei, M., Terracciano, S., & Sadoul, K. (2007) · ChemMedChem · doi:10.1002/cmdc.200700095 · Cited by 37
An, Z., Gluck, C. B., Choy, M. L., & Kaufman, L. J. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.12.006 · Cited by 37
Conformationally Locked Calixarene-Based Histone Deacetylase Inhibitors
Chini, M. G., Terracciano, S., Riccio, R., Bifulco, G., Ciao, R., Gaeta, C., Troisi, F., & Neri, P. (2010) · Organic Letters · doi:10.1021/ol102420b · Cited by 37
Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype
Berry, N. B., & Bapat, S. A. (2008) · Journal of Ovarian Research · doi:10.1186/1757-2215-1-8 · Cited by 37
Park, H., & Lee, S. (2004) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-004-2283-3 · Cited by 37
de Oliveira, J. C. (2012) · Semina Ciências Biológicas e da Saúde · doi:10.5433/1679-0367.2012v33n1p21 · Cited by 37
Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD)
Bourguet, E., Ozdarska, K., Moroy, G., Jeanblanc, J., & Naassila, M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00115 · Cited by 36
Targeting JAK2 in the therapy of myeloproliferative neoplasms
Reddy, M. M., Deshpande, A. J., & Sattler, M. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.662956 · Cited by 36
Vanommeslaeghe, K., Alsenoy, C. V., Proft, F. D., Martins, J. C., Tourwé, D., & Geerlings, P. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b304707e · Cited by 36
Photocontrolled activation of small molecule cancer therapeutics
Dcona, M. M., Mitra, K., & Hartman, M. C. T. (2020) · RSC Medicinal Chemistry · doi:10.1039/d0md00107d · Cited by 36
Ganai, S. A., Abdullah, E., Rashid, R., & Altaf, M. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00357 · Cited by 36
Structural Basis for the Selective Inhibition of HDAC10, the Cytosolic Polyamine Deacetylase
Herbst‐Gervasoni, C. J., Steimbach, R. R., Morgen, M., Miller, A. K., & Christianson, D. W. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00362 · Cited by 36
Epigenetic regulation of motivated behaviors by histone deacetylase inhibitors
Elvir, L., Duclot, F., Wang, Z., & Kabbaj, M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.09.030 · Cited by 36
Nielsen, T. K., Hildmann, C., Riester, D., Wegener, D., Schwienhorst, A., & Ficner, R. (2007) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309107012377 · Cited by 36
Metadata
- Authors
- Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Columbia University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Pavletich, Nikola P.
- Venue
- Nature
- Published
- 1999-09
- Volume
- 401
- Issue
- 6749
- Pages
- 188-193
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2135830745
- Cited by
- 1,714
- References
- 28
- Citations by year
- 2026: 39 · 2025: 48 · 2024: 40 · 2023: 55 · 2022: 28 · 2021: 66 · 2020: 62 · 2019: 50 · 2018: 52 · 2017: 70 · 2016: 68 · 2015: 74 · 2014: 67 · 2013: 78 · 2012: 82
- FWCI
- 12.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Genentech
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- histone deacetylase, histone deacetylase inhibitors, trichostatin A, vorinostat, Aquifex aeolicus, crystal structure, catalytic site, zinc binding site, hyperthermophilic bacteria, anticancer agents, promyelocytic leukemia
- MeSH terms
- Vorinostat, Amino Acid Sequence, Enzyme Inhibitors, Escherichia coli, Histone Deacetylases, Humans, Hydroxamic Acids, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Conformation, Recombinant Fusion Proteins, Zinc, Gram-Negative Aerobic Rods and Cocci, Sequence Homology, Amino Acid, Crystallography, X-Ray, Catalytic Domain, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.